Filter by: patients
Home > Community Treatment Reports and Side Effects > Cefdinir Treatment Report
What is Cefdinir?

Cefdinir is a cephalosporin antibiotic used for the treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute bacterial otitis media, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
General health 2 2 Efficacy_moderate Efficacy_slight
Other 1 0
Ear infection 1 1 Efficacy_slight
Bronchitis 1 1 Efficacy_major

See all 2 patients currently taking Cefdinir

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 3

Reported Dosages

  600 mg m,w,f 600 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Cefdinir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 3   Course of treatment ended: 75%
Doctor's advice 1   Doctor's advice: 25%

See all 4 patients who’ve stopped taking Cefdinir

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Cefdinir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Cefdinir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Cefdinir

Always
 3 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Cefdinir

Very
 0 0%
Somewhat
 0 0%
A little
 1 33%
Not at all
 2 67%

Cost

Paid out of pocket

Cost of Cefdinir

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 2 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.